Business Context and Reporting Period
Company: BIOHARVEST SCIENCES INC.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2025
Date Filed: August 13, 2025
Principal Executive Offices: 1140-625 Howe Street, Vancouver, British Columbia, Canada
This filing serves as a cover document to submit a news release dated August 13, 2025 (Exhibit 99.1). The registrant files annual reports under Form 40-F.
Key Financial Metrics
The provided filing text is a cover sheet and does not contain specific financial data. The following metrics are not disclosed in this document:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Note: Detailed financial figures would be contained within the attached Exhibit 99.1 (News Release), which is not included in the input text.
Material Changes
The filing text does not provide details regarding material changes versus prior periods. The purpose of this specific document is to reference the submission of a news release.
Guidance, Outlook, and Risks
No management commentary, forward-looking guidance, risk factors, or contingencies are explicitly stated in the cover sheet text. These items are likely detailed in the referenced news release (Exhibit 99.1).
Investor Verification Checklist
- Review the full text of Exhibit 99.1 (News Release dated August 13, 2025) for the actual announcement content.
- Verify if the news release contains updates on clinical trials, regulatory approvals, or partnership agreements typical for a biotechnology firm.
- Check the company's most recent Form 40-F for baseline financial data to compare against any new information in the news release.
- Confirm the identity of the signatory, David Ryan (Vice-President, Investor Relations & Secretary), and his authority to release the information.